Eden Biodesign and the University of Manchester Intellectual Property Limited develop cancer treatment
08-Aug-2007 -
Eden Biodesign Ltd, announced that it has been selected by the University of Manchester Intellectual Property Limited (UMIP) to provide a range of services for the development of a novel therapeutic for treatment of macular degeneration and cancer.
Professor Paul Bishop, School of Medicine, ...
biologics
biotechnology
services